Thyroid hormone receptor-beta agonists in NAFLD therapy: possibilities and challenges. Li LM, Song Y, Shi YQ, Sun LL, et al. J Clin Endocrinol Metab 2023 Feb 7:dgad072. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li LM, Song Y, Shi YQ, Sun LL, et al. Thyroid hormone receptor-beta agonists in NAFLD therapy: possibilities and challenges. J Clin Endocrinol Metab 2023 Feb 7:dgad072. doi: 10.1210.
PMID: 36746649